Mabwell (Shanghai) Bioscience Co., Ltd. Stock
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.64 CNY | -1.16% | -8.29% | -3.21% |
May. 24 | Mabwell Announces 9MW2821 Clinical Data | CI |
May. 13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
Sales 2024 * | 335M 46.19M | Sales 2025 * | 992M 137M | Capitalization | 12.64B 1.74B |
---|---|---|---|---|---|
Net income 2024 * | -919M -127M | Net income 2025 * | -641M -88.45M | EV / Sales 2024 * | 37.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.7 x |
P/E ratio 2024 * |
-13.8
x | P/E ratio 2025 * |
-19.7
x | Employees | 1,491 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.33% |
1 day | -1.16% | ||
1 week | -8.29% | ||
Current month | -8.29% | ||
1 month | -11.87% | ||
3 months | +7.73% | ||
6 months | +4.53% | ||
Current year | -3.21% |
Managers | Title | Age | Since |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 23-06-26 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 20-10-10 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 19-03-31 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 31.64 | -1.16% | 2,497,064 |
24-06-06 | 32.01 | -4.16% | 3,670,342 |
24-06-05 | 33.4 | -2.74% | 2,536,036 |
24-06-04 | 34.34 | -0.32% | 2,509,453 |
24-06-03 | 34.45 | -0.14% | 3,586,463 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.21% | 1.74B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- 688062 Stock